Squarepoint’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Squarepoint’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,474	Closed	-$19K	–	3712
2021 Q4	$19K	Sell	1,474 -1,829	-55%	-$30.2K	﹤0.01%	3086
2021 Q3	$76K	Buy	3,303 +1,303	+65%	+$38.8K	﹤0.01%	2721
2021 Q2	$88K	Sell	2,000 -4,847	-71%	-$270K	﹤0.01%	3040
2021 Q1	$497K	Sell	6,847 -1,271	-16%	-$90.3K	﹤0.01%	2027
2020 Q4	$351K	Buy	+8,118	New	+$364K	﹤0.01%	2091
2020 Q3	–	Sell	-2,567	Closed	-$154K	–	2935
2020 Q2	$154K	Buy	2,567 +743	+41%	+$68.1K	﹤0.01%	1904
2020 Q1	$137K	Buy	1,824 +666	+58%	+$76.7K	﹤0.01%	1580
2019 Q4	$159K	Buy	+1,158	New	+$141K	﹤0.01%	2270

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Squarepoint's ORTX Position: Q1 2022 in Review

Squarepoint sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022, closing a stake of 1,474 shares — an estimated $19K sold.

Squarepoint first reported a position in ORTX in Q4 2019 and held it in 8 quarters. The position peaked at $497K in Q1 2021. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

Squarepoint reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Squarepoint sold 1,474 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $19K.
Squarepoint first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 8 quarters.
Squarepoint's Orchard Therapeutics plc American Depositary Shares position peaked at $497K in Q1 2021.
61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.